missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Alpelisib, MedChemExpress
Beschreibung
Alpelisib (BYL-719) is a potent, selective, and orally active PI3Kα inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110α/p110γ/p110δ/p110β with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity.
Specifications
Specifications
| Chemischer Name oder Material | Alpelisib |
| CAS | 1217486-61-7 |
| Farbe | Off-White |
| Hinweise zur Reinheitsqualität | Research |
| Summenformel | C19H22F3N5O2S |
| Menge | 5 mg |
| Synonym | BYL-719 |
| Löslichkeitsinformationen | DMSO : 83.33 mg/mL (188.76 mM; Need ultrasonic) |
| SMILES | CC(N=C(S1)NC(N2CCC[C@H]2C(N)=O)=O)=C1C3=CC(C(C)(C(F)(F)F)C)=NC=C3 |
| Molekulargewicht (g/mol) | 441.47 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?